⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3502125 | 0.82 | — | — | |
| SCHEMBL29184392 | 0.81 | ELANE (0.37) | — | |
| SCHEMBL30688676 | 0.81 | KCNN4 (0.34) | — | |
| SCHEMBL6755569 | 0.80 | DGAT1 (0.39) | — | |
| SCHEMBL8037991 | 0.80 | — | — | |
| SCHEMBL3358751 | 0.80 | — | — | |
| SCHEMBL28292106 | 0.80 | DGAT1 (0.39) | — | |
| SCHEMBL29025486 | 0.78 | — | — | |
| SCHEMBL2703489 | 0.78 | — | — | |
| SCHEMBL675195 | 0.78 | CYP4F2 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250171417-A1 | HETEROCYCLIC DERIVATIVE, AND COMPOSITION AND PHARMACEUTICAL USE THEREOF | XIZANG HAISCO PHARMACEUTICAL CO., LTD. (CN) | 2025-05-29 | — | — | US | disclosed |
| CN-119464403-A | Buwa western medicine Synthesis method of tam | 浙江普洛家园药业有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-118475567-A | Heterocyclic derivative, composition and pharmaceutical application thereof | 西藏海思科制药有限公司 | 2024-08-09 | — | — | CN | disclosed |
| EP-4385985-A1 | HETEROCYCLIC DERIVATIVE, AND COMPOSITION AND PHARMACEUTICAL USE THEREOF | Xizang Haisco Pharmaceutical Co., Ltd. (CN) | 2024-06-19 | — | — | EP | disclosed |
| WO-2024034583-A1 | METHOD FOR PRODUCING HALOGENATED ALKENE COMPOUND | ダイキン工業株式会社 | 2024-02-15 | — | — | WO | disclosed |
| US-11746178-B2 | Polymer production method and radical polymerization initiating group-containing compound | DAINICHISEIKA COLOR & CHEMICALS MFG. CO., LTD. (JP) | 2023-09-05 | — | — | US | disclosed |
| WO-2023016518-A1 | HETEROCYCLIC DERIVATIVE, AND COMPOSITION AND PHARMACEUTICAL USE THEREOF | 四川海思科制药有限公司 | 2023-02-16 | — | — | WO | disclosed |
| WO-2023016518-A1 | HETEROCYCLIC DERIVATIVE, AND COMPOSITION AND PHARMACEUTICAL USE THEREOF | 四川海思科制药有限公司 | 2023-02-16 | — | — | WO | disclosed |
| EP-3444254-B1 | HETEROCYCLIC-SUBSTITUTED PYRIDINOPYRIMIDINONE DERIVATIVE AS CDK INHIBITOR AND USE THEREOF | SHANGHAI XUNHE PHARMACEUTICAL TECH CO LTD (CN) | 2020-05-13 | — | — | EP | disclosed |
| US-10351578-B2 | Heterocyclic-substituted pyridinopyrimidinone derivative as CDK inhibitor and use thereof | Shanghai Xunhe Pharmaceutical Technology Co. Ltd. (CN) | 2019-07-16 | — | — | US | disclosed |
| WO-2010009290-A1 | ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR INHIBITORS | WYETH (US) | 2010-01-21 | — | — | WO | disclosed |
| CN-101389324-A | Azaindole inhibitors of aurora kinases | SMITHKLINE BEECHAM CORP (US) | 2009-03-18 | — | — | CN | disclosed |
| US-20070270521-A1 | Transition metal compound, polymerization-initiator system comprising the same, and process for producing polymer | SUMITOMO CHEMICAL COMPANY, LIMITED | 2007-11-22 | — | — | US | disclosed |
| EP-0996621-A1 | NOVEL COMPOUNDS | Astra Pharmaceuticals Limited (GB) | 2000-05-03 | — | — | EP | disclosed |
| WO-1999005143-A1 | NOVEL COMPOUNDS | ASTRA PHARMACEUTICALS LTD. (GB) | 1999-02-04 | — | — | WO | disclosed |
| EP-0839032-A4 | HYDROXYL IONS AS UNIQUE THERAPEUTIC AGENTS AND COMPOUNDS THAT MODULATE IONS, COMPOUNDS | FHJ SCIENT INC (US) | 1998-07-08 | — | — | EP | disclosed |
| EP-0839032-A1 | HYDROXYL IONS AS UNIQUE THERAPEUTIC AGENTS AND COMPOUNDS THAT MODULATE IONS, COMPOUNDS | FHJ SCIENTIFIC, INC. (US) | 1998-05-06 | — | — | EP | disclosed |
| US-5679711-A | Hydroxyl ions as novel therapeutic agents and compounds that modulate these ions, compositions employing these agents, therapeutic methods for using such agents | FHJ SCIENTIFIC, INC. (US) | 1997-10-21 | — | — | US | disclosed |
| WO-1996040104-A1 | HYDROXYL IONS AS UNIQUE THERAPEUTIC AGENTS AND COMPOUNDS THAT MODULATE IONS, COMPOUNDS | FHJ SCIENTIFIC, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| US-3970694-A | ANTICHOLESTEROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-07-20 | — | — | US | disclosed |